Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
(1) To evaluate the efficacy of suvorexant compared with placebo in improving insomnia, as measured by change from baseline in PSG-derived total sleep time (TST), at Week 4. (2) To evaluate the safety and tolerability of suvorexant for up to 4 weeks of treatment.
Inclusion criteria
- Insomnia